Anixa Biosciences, Inc. (ANIX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 134.04M |
| Enterprise Value | 133M |
| P/E Ratio | -9.67 |
| PEG Ratio | 0.01 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 6.97 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -9.39 |
Fiscal Year
| Fiscal Year | October 31, 2025 |
| Most Recent Quarter | July 31, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -0.69 |
| Return On Equity | -0.7 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -36,000 |
| EBITDA | -10.99M |
| Net Income | -10.93M |
| Diluted EPS | -0.34 |
Balance Sheet
| Total Cash | 13.86M |
| Total Cash/Share | 0.41 |
| Total Debt | 174,000 |
| Total Debt/Equity | 0.01 |
| Current Ratio | 8.54 |
| Book Value Per Share | 0.39 |
Price History
| 52-Week Change | -9.79 |
| 52-Week High | 5.46 |
| 52-Week Low | 2.32 |
| Moving Average 50 Days | 3.2 |
| Moving Average 200 Days | 3.01 |
Statistics
| Average Volume | 293,425 |
| Shares Outstanding | 34.02M |
| % Held by Institutions | 15.94 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
| Last Split Date | June 26, 2015 |
AD
